Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
05:15pAbbVie Says FDA Approves Qulipta as Migraine Treatment
DJ
02:54pPRESS RELEASE : Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics
DJ
02:43pCatalyst Bio Gets Orphan Drug Designation for MarzAA to Treat Factor VII Deficiency
DJ
02:30pAURORA CANNABIS : targets more cost cuts on path to profitability
RE
01:25pTeva Pharma Shares Up 6% After Louisiana Opioid Settlement
DJ
12:01pPRESS RELEASE : Abivax late-breaking abstract presentation and Live Industry Symposium at the UEG Week Virtual 2021
DJ
12:01pAbivax presente un ź late-breaking abstract ╗ et organise un live symposium lors du congres UEG Week Virtual 2021
DJ
08:42aASTRAZENECA : Credit Suisse maintains a Buy rating
MD
07:50aASTRAZENECA : Receives a Buy rating from Jefferies
MD
07:46aRIVERSTONE : Goldman's Petershill Partners slides after being valued at $5.5 billion in IPO
RE
07:40aSANOFI : JP Morgan maintains a Buy rating
MD
07:36aECKERT & ZIEGLER : Hauck & Aufhauser reaffirms its Buy rating
MD
07:03aMODERNA : Pfizer submits data for COVID-19 vaccine use in younger kids
RE
07:03aZogenix Seeks FDA Expanded OK of Fintepla in Lennox-Gastaut Syndrome
DJ
06:31aHCA Healthcare Names McAlevey Legal Chief as Waterman Retires
DJ
Discover
06:11aABERA BIOSCIENCE : France's Avril in talks with Bigard group to sell two pork firms
RE
05:57aViiV Gets FDA Priority Review for Cabotegravir Long-Acting for HIV Prevention
DJ
05:35aRegeneron Gets FDA Priority Review of Libtayo in Advanced Cervical Cancer
DJ
05:15aPfizer, BioNTech to Request FDA Emergency-Use Authorization for Covid-19 Shot in Children in Coming Weeks
DJ
04:57aLilly Cuts List Price of Insulin Lispro Injection
DJ
04:30aLOTUS PHARMACEUTICALS : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund
RE
03:34aNOVO NORDISK : JP Morgan reiterates its Buy rating
MD
03:05aAMP Alternative Medical Products Inc. Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany
CI
02:57aSanofi to Halt MRNA Covid-19 Vaccine Development Despite Positive Trial Results -- Update
DJ
02:13aSanofi to Halt MRNA Covid-19 Vaccine Development
DJ
02:00aAnimalcare Group plc Declares Interim Dividend, Payable on 19 November 2021
CI
02:00aEpisurf Medical AB Investigates the Opportunities for Launching an Implant for the MTP Joint in the US Market
CI
02:00aAstraZeneca's Saphnelo Approves in Japan for Systemic Lupus Erythematosus
CI
02:00aSourcebio International plc Reports Consolidated Earnings Results for the Six Months Ended 30 June 2021
CI
02:00aYourgene Health plc Provides Revenue Guidance for the First Half Year to September 30, 2021
CI
02:00aBonesupport Announces Supplementary US Denovo Application Submitted
CI
02:00a4basebio PLC Commences Development of its Pilot Clean Room Project for the Purpose of Manufacturing GMP Standard DNA
CI
02:00aOxford Biodynamics Plc Completes Its Move into Its New Purpose-Built Facility on the Oxford Business Park
CI
02:00aSanofi Announces Positive Phase 1/2 Study Interim Results for Its First mRNA-Based Vaccine Candidate
CI
02:00aSedana Medical Receives Approval in Germany
CI
01:01aRelief Reports that its U.S. Collaboration Partner has Announced Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMITM (RLF-100TM/aviptadil)
DJ
01:00aKuros Biosciences to Showcase New Magnetos Products At Nass 2021 Annual Meeting
CI
01:00aValneva and Pfizer Reports Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate
CI
01:00aBone Therapeutics Signs Research Partnership with Implant Therapeutics to Access Induced Pluripotent Stem Cells
CI
12:50aAstraZeneca's Saphnelo Approved in Japan for SLE
DJ
12:33aSanofi Reports Encouraging Early Results In Covid-19 mRNA Vaccine Candidate
DJ
09/28Certain A Shares of Imeik Technology Development Co.,Ltd. are subject to a Lock-Up Agreement Ending on 28-SEP-2021.
CI
09/28Certain A Shares of Touchstone International Medical Science Co., Ltd. are subject to a Lock-Up Agreement Ending on 28-SEP-2021.
CI
09/28Brii Biosciences Limited Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy
CI
09/27Shionogi & Co., Ltd. Announces Initiation of A Phase 2/3 Clinical Trial for A COVID-19 Therapeutic Agent in Japan
CI
09/27Imricor Medical Systems, Inc. Enters into a Sales Distribution Agreement with MiRTLE Medical, LLC
CI
09/27BioArctic AB's partner Eisai Initiates Rolling Submission for the US FDA Biologics License Application of Lecanemab for Early Alzheimer’s Disease Under the Accelerated Approval Pathway
CI
09/27Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab For Early Alzheimer's Disease Under The Accelerated Approval Pathway
CI
09/27AURORA CANNABIS : revenue falls short of expectations on lower pot demand
RE
09/27LBT Innovations Limited Appoints Brian O'Dwyer to Its Board as a Non-Executive Director, Commencing 4 October 2021
CI
09/27Merck Reportedly in Advanced Talks to Buy Acceleron Pharma
CI
09/27ACCELERON PHARMA : Merck in advanced talks to buy Acceleron Pharma - WSJ
RE
09/27Teligent, Inc. Announces Executive Changes
CI
09/27Centene Corporation Announces Resignation of Jeffrey A. Schwaneke as Executive Vice President of Healthcare Enterprises of Centene
CI
09/27Gilead Announces Fifth Approval for Trodelvy in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative with Health Canada Authorization
CI
09/27Hologic, Inc. Together with Certain of its Subsidiaries Enters into Refinancing Amendment No. 2 to its Amended and Restated Credit and Guaranty Agreement
CI
09/27Globus Medical, Inc. Announces First ExcelsiusGPS« Cranial Surgery
CI
09/27Pfizer Inc. Announces First Participants Dosed in Phase 1 Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Single Dose Quadrivalent mRNA Vaccine Against Influenza in Healthy Adults
CI
09/27Assisted 4 Living, Inc. Appoints David Verinder to the Board of Directors of the Company
CI
09/27Natus Medical Incorporated Receives Key New Government Contract
CI
09/27Summers Value Partners Enters into Cooperation Agreement with Electromed
CI
09/27Biodelivery Sciences International, Inc. Elects to Repay $20 Million Plus Accrued Interest, Representing A Portion of the First Tranche of Its Previously Disclosed Loan Agreement with BPCR Limited Partnership
CI
09/27Becton, Dickinson and Company Enters into an Amended and Restated Credit Agreement
CI
09/27Brookdale Senior Living Inc. to Offer $200 Million Convertible Senior Notes Due 2026
CI
09/27Vapotherm, Inc. Announces Executive Changes
CI
Discover
09/27MacroGenics, Inc. Announces Paulo Costa, Member of the Board of Directors Will Not Stand for Re-Election as A Director
CI
09/27Beyond Air« Provides Global Regulatory Update for Lungfit« Ph
CI
09/27Intersect ENT, Inc. Enters into Facility Agreement
CI
09/27Paratek Pharmaceuticals, Inc. Announces Additional Funding Under the BARDA Contract to Advance the Development of NUZYRA (omadacycline) for Post-Exposure Prophylaxis and Treatment of Pulmonary Anthrax
CI
09/27MODERNA : U.S. administers 390.7 mln doses of COVID-19 vaccines - CDC
RE
1  2  3  4  5  6  7  8  9  10Next